搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Psychology Today
2 天
How Huntington's Disease Helped Me Find My Magic
The Wicked Witch of the West and I have something in common: We both use our fatal flaws to our advantage—for her, her green ...
Deccan Chronicle
4 天
Huntington’s Disease: The Genetic Brain Decay
Huntington’s disease poses a threat to the brain—the core governing system of sensation, intellectual ability, nerve-related ...
labiotech
9 天
Huntington’s disease: a therapeutic field on a bumpy ride
After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...
Yahoo
8 天
One man's shares his experience living with Huntington's Disease
Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...
18 天
Artists with Huntington's disease create exhibition
The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.
KTTV
8 天
One man shares his experience living with Huntington's Disease
Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...
BioSpace
5 天
Embattled Sage Dealt Deeper Blow With Huntington’s Failure
Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts ...
BioSpace
10 天
Sage Scraps Huntington’s Hopeful After Disappointing Phase II Data
After previously failing studies in Parkinson’s and Alzheimer’s, dalzanemdor’s latest stumble in Huntington’s disease has ...
FierceBiotech
10 天
Sage drops dalzanemdor as Huntington's failure completes clean sweep of midphase flops
Alzheimer’s and Huntington’s patients do have different symptoms and disease biology, but that made no difference to the ...
pharmaphorum
10 天
Sage wilts as Huntington's prospect flunks trial
Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for cognitive ...
GlobalData on MSN
9 天
Sage ends dalzanemdor development following Phase II trial failure
The Phase II DIMENSION study of Sage's dalzanemdor failed to meet its primary and secondary endpoints for treating Huntington ...
10 天
on MSN
Sage slips as Huntington’s Disease therapy fails in mid-stage trial
Shares of Sage Therapeutics (NASDAQ:SAGE) fell in the premarket on Wednesday after the company said dalzanemdor, its ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈